CARGO Therapeutics, Inc. (CRGX)
NASDAQ: CRGX · Real-Time Price · USD
14.89
+0.23 (1.57%)
Dec 26, 2024, 4:00 PM EST - Market closed
CARGO Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for CARGO Therapeutics stock have an average target of 31.8, with a low estimate of 28 and a high estimate of 34. The average target predicts an increase of 113.57% from the current stock price of 14.89.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 15, 2024.
Analyst Ratings
The average analyst rating for CRGX stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 | 4 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 8 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $33 | Strong Buy | Reiterates | $33 | +121.63% | Nov 15, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $28 | Strong Buy | Maintains | $28 | +88.05% | Nov 13, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $37 → $34 | Buy | Maintains | $37 → $34 | +128.34% | Aug 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $33 | Strong Buy | Reiterates | $33 | +121.63% | Aug 13, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
725.66K
EPS This Year
-3.85
from -16.53
EPS Next Year
-4.19
from -3.85
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | 5.2M | 192.7M | |||
| Avg | n/a | 725,659 | 43.5M | |||
| Low | n/a | n/a | 6.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | 26,453.8% | |||
| Avg | - | - | 5,894.1% | |||
| Low | - | - | 845.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -3.74 | -3.31 | -2.50 | |||
| Avg | -3.85 | -4.19 | -4.05 | |||
| Low | -4.07 | -4.76 | -4.95 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.